GoodRx
About GoodRx
GoodRx helps Americans save on prescriptions. Americans spend over $400 billion a year on prescriptions, and too many people simply can't find affordable prescriptions. Even if you have insurance or Medicare. We offer a website and mobile apps that collects current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US. GoodRx is used by thousands of physicians and millions of Americans each month. We have saved Americans over $3 billion. We are not going to rest until prescriptions are affordable for all Americans. We also offer GoodRx for Benefits, which provides technology solutions for health plans, payors and PBM's in an easy-to-understand website and mobile app experience. Learn more at www.goodrx.com/benefits.
Recent News
TandemAI Closes $22M Series A Extension Round
White House Adds Generic Drugs to Direct-to-Consumer TrumpRx Site
How Price Transparency Could Fix the Abandoned Rx Issue: Laura Jensen
Don’t Give up on Your Part D Costs
What Are Peptides And Why Is Everyone Talking About Them?
Transparent Healthcare Prices Won’t Lower Patients’ Costs
Novartis Slashes 114 More Jobs at New Jersey HQ
Google March 2026 Core Update Visibility Shifts & Patterns In the US
GoodRx Launches Companion Subscription As Insurance Add-On
The Next Frontier For GLP-1 Medications: Potential Therapy For Inflammation
TrumpRx Adds Generic Drugs, With Mark Cuban, GoodRx and Amazon
Here’s How Much Weight-Loss Drugs Wegovy, Zepbound and Foundayo Cost — and How to Pick the Best GLP-1 for You
Strategies for Delivering Smarter Pharmacy Benefits
Strategy Pivot Hits GoodRx
Pharma Pulse: TrumpRx Goes Generic and the FDA Loses More Leaders
The Link Between Mental Health and Weight Loss: What You Need to Know
10 Healthcare IT Solutions Helping Patients Navigate GLP-1 Medication Costs
Hims & Hers Launches Integrated AI‑Driven Digital Health Platform
Kaufman Investments, Two Sigma Real Estate Snap Up Boutique Office Building for $52M
GoodRx Partners with Novo Nordisk to Offer Self-Pay Pricing for New Oral Ozempic® Pill
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
GoodRx Expands Cash-Pay Access to Oral Ozempic for Patients With Type 2 Diabetes
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
Wegovy HD Now Available on GoodRx for $399 Per Month Self-Pay
TrumpRx Joins Forces With Mark Cuban, Features More Than 600 Generics
How Fintech and Logistics Innovation Are Streamlining Deceased Estate Cleanouts
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
Why Men Struggle in Silence: The Hidden Link Between Mental Health and Addiction
FDA Enforcement on Copycat GLP-1's Could Reshape Retail Pharmacy Economics: Q&A with David Graziano
Descope Introduces Dedicated Identity Infrastructure for AI Agents and MCP Ecosystems
After 25 Years Of Consumer-Directed Healthcare, What’s Missing?
Debt‑Negotiation Expert Carrie Joy Grimes Offers Practical Tools to Cut Household Bills
Direct-To-Consumer Drug Portals Offer Lower Prices, But Preserve Inequities
Phathom Pharmaceuticals Inc (PHAT) Q1 2026 Earnings Call Transcript
Descope Leads 2026 CIAM Rankings as Enterprises Prioritize No‑Code Identity
Pharma Pulse: Walgreens’ New Hybrid Pharmacist Model, Pharmacies Expand Injectable Access, and More
Dr. Oz Fires Back After Joy Behar's TrumpRx Meltdown
Restrictions on Obesity Drug Coverage Force Patients to Pivot
Kin Health Raises $9M to Build an AI Notetaker for Patients
Google’s March Core Update Shifted Visibility Away From Aggregators via @Sejournal, @MattGSouthern
Recent Deals
No recent deals for this company.